Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual-acting hybrid antibiotics: a promising strategy to combat bacterial resistance
Authors
Keywords
-
Journal
Expert Opinion on Drug Discovery
Volume 5, Issue 9, Pages 883-902
Publisher
Informa Healthcare
Online
2010-07-22
DOI
10.1517/17460441.2010.508069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluation of amphiphilic aminoglycoside–peptide triazole conjugates as antibacterial agents
- (2010) Smritilekha Bera et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Discovery of novel antibacterials
- (2010) J Richard Miller et al. Expert Opinion on Drug Discovery
- Multidrug-Resistant Gram-Negative Infections
- (2009) Helen Giamarellou et al. DRUGS
- Promise and challenges in drug discovery and development of hybrid anticancer drugs
- (2009) Lalji K Gediya et al. Expert Opinion on Drug Discovery
- Novel heterodimer antibiotics: a review of recent patent literature
- (2009) Daniel D Long et al. Future Medicinal Chemistry
- A Multivalent Approach to Drug Discovery for Novel Antibiotics
- (2009) Daniel D Long et al. JOURNAL OF ANTIBIOTICS
- Exploring the Positional Attachment of Glycopeptide/β-lactam Heterodimers
- (2009) Daniel D Long et al. JOURNAL OF ANTIBIOTICS
- Design, Synthesis, and Evaluation of Novel Fluoroquinolone−Aminoglycoside Hybrid Antibiotics
- (2009) Varvara Pokrovskaya et al. JOURNAL OF MEDICINAL CHEMISTRY
- Drug interactions and the evolution of antibiotic resistance
- (2009) Pamela J. Yeh et al. NATURE REVIEWS MICROBIOLOGY
- Antibiotic-Resistant Bugs in the 21st Century — A Clinical Super-Challenge
- (2009) Cesar A. Arias et al. NEW ENGLAND JOURNAL OF MEDICINE
- In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Microbiology Profiling Studies with Staphylococci and Streptococci
- (2008) G. T. Robertson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Evaluation of CBR-2092, a Novel Rifamycin-Quinolone Hybrid Antibiotic: Studies of the Mode of Action in Staphylococcus aureus
- (2008) G. T. Robertson et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The Vancomycin−Nisin(1−12) Hybrid Restores Activity against Vancomycin Resistant Enterococci†
- (2008) Christopher J. Arnusch et al. BIOCHEMISTRY
- How many modes of action should an antibiotic have?
- (2008) H BROTZOESTERHELT et al. CURRENT OPINION IN PHARMACOLOGY
- Synthesis and antimalarial evaluation of novel pyridine quinoline hybrids
- (2008) Badri Narayan Acharya et al. MEDICINAL CHEMISTRY RESEARCH
- Accelerated evolution of resistance in multidrug environments
- (2008) M. Hegreness et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drug interactions modulate the potential for evolution of resistance
- (2008) J.-B. Michel et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started